TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Tizona Therapeutics, Inc
Tizona Therapeutics, Inc
Essen Biotech
Takeda
Novartis
Coherus Oncology, Inc.
Memorial Sloan Kettering Cancer Center
DEKA Biosciences
Nimbus Therapeutics
Inhibrx Biosciences, Inc
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Kineta Inc.
Cambridge University Hospitals NHS Foundation Trust
Syndax Pharmaceuticals